Cite
APA Citation
Kurino, T., Matsuda, R., Terui, A., Suzuki, H., Kokubo, T., Uehara, T., Arano, Y., Hisaka, A., & Hatakeyama, H. (2020). poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models. Journal for immunotherapy of cancer, 8(1), . http://access.bl.uk/ark:/81055/vdc_100127575583.0x00003a